HIV / AIDS in the News

Gilead’s experimental HIV treatment meets main goal in late-stage trial - TradingView — Track All Markets

 

Gilead’s experimental HIV treatment meets main goal in late-stage trial - Yahoo

 

Gilead’s experimental HIV treatment meets main goal in late-stage trial - TradingView — Track All Markets

 

POZ Poll: Nationwide, new HIV cases dropped 19% between 2010 to 2022, but New York City just reported a 5.4% uptick from 2023 to 2024. How do you think overall U.S. rates will change in 2026? - POZ

 

Gilead (Nasdaq: GILD) to base HIV filings on Phase 3 ARTISTRY BIC/LEN trials - Stock Titan

 

Gilead’s Investigational Single-Tablet Regimen of Bictegravir and Lenacapavir for HIV Treatment Meets Primary Endpoint in Phase 3 ARTISTRY-2 Trial - Yahoo Finance

 

Enhancing HIV Prevention for Recently Released Inmates - BIOENGINEER.ORG

 

HIV Ireland’s dangerous message - Gript

 

Blazing a new path for HIV prevention: A discussion with Dr. Moupali Das - Yale School of Public Health

 

Does India’s HIV success story overlook its poorest state? - South China Morning Post

 

HIV infections increased across New York. Experts say it's a result of the pandemic - WXXI News

 

Gilead builds case for new HIV pill with second positive Phase III study - FirstWord Pharma

 

Researchers See Dramatic Drop in HIV-Infected Immune Cells in Patient After Cancer Treatment Received - Johns Hopkins Medicine

 

Chemotherapy may reduce HIV-infected T cells - News-Medical

 

Zimbabwe to roll out long-acting HIV prevention drug in 2026 - APAnews - Agence de Presse Africaine

 

Debunking six myths about HIV - The Indian Express

 

How Primary Care Clinicians Can Help Prevent Cancer in People Living with HIV - Clinical Advisor

 

A North Carolina man with HIV has admitted to removing an IV from his arm and "spraying his blood" into the eyes of two different hospital workers while being treated by them for "diabetic reasons," according to court documents. Kameron Gilchrist, who…

 

HCV coinfection linked to higher rates of drug-induced liver injury in TB - European AIDS Treatment Group

 

Concurrent TB-HIV therapy controls reactivation, not inflammation - European AIDS Treatment Group

 

Man with HIV admits to 'spraying his blood' into eyes of hospital workers who were treating him after he plucked IV out of his arm, used it as 'deadly weapon' - Law and Crime News

 

Opinion | I Co-Discovered HIV. Here Are Lessons to Help Prepare for the Next Threat. - MedPage Today

 

Plot to kill blacks with HIV exposed - sundayworld.co.za

 

HIV-Infected CD4+ T Cells Use Sialoglycans to Evade Myeloid Immune Response - geneonline.com

 

Choose U ambassadors share lived experiences with HIV, personal reflections, and insights - Los Angeles Blade

 

HIV Alters CD4+ T Cells to Evade Immunity - Bioengineer.org

 

ICYMI: Highlights From CROI 2025 - The American Journal of Managed Care® (AJMC®)

 

Study at Lira Hospital Finds Seroconversion Rates Among HIV-Exposed Infants and Factors Influencing Transmission - geneonline.com

 

HIV Exposure: Sero-conversion Rates in Infants Studied - Bioengineer.org

 

The Health Foundation adds $100K in emergency assistance for Hoosiers living with HIV/AIDS - WRTV